Trademark Overview
On Friday, December 2, 2005, a trademark application was filed for ZYMERUS with the United States Patent and Trademark Office. The USPTO has given the ZYMERUS trademark a serial number of 78765780. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Sunday, November 26, 2006. This trademark is owned by Eli Lilly and Company. The ZYMERUS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely pharmaceutical preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous system diseases and disorders, dermatological disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, urological disorders
